Home » Topics » Regulatory

Regulatory
RSS

sNDA submitted for Prevacid in pediatric patients

Feb. 21, 2002

Commonly used antibiotic shows potential for Rx of multiple sclerosis

Feb. 21, 2002

Aciphex indications expanded

Feb. 19, 2002

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Feb. 15, 2002

Clarinex approved by FDA for perennial allergic rhinitis and chronic idiopathic urticaria

Feb. 14, 2002

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002